A phase II study of isoflavone, gemcitabine, and erlotinib in locally advanced (LA) or metastatic pancreatic cancer

被引：0
|
作者：
Hammad, N.
Philip, P. A.
Shields, A. F.
Sarkar, F. H.
Abruzzese, J. L.
Kaseb, A. O.
Javle, M. M.
Varadhachary, G. R.
Wolff, R. A.
El-Rayes, B. F.
机构：
[1] Karmanos Canc Ctr, Detroit, MI USA
[2] Wayne State Univ, Detroit, MI USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15540
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15540
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer
    Renouf, D. J.
    Tang, P. A.
    Hedley, D.
    Chen, E.
    Kamel-Reid, S.
    Tsao, M. S.
    Tran-Thanh, D.
    Gill, S.
    Dhani, N.
    Au, H. J.
    Wang, L.
    Moore, M. J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (11) : 1909 - 1915
  • [2] A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer
    Bassel Fuad El-Rayes
    Philip A. Philip
    Fazlul H. Sarkar
    Anthony F. Shields
    Ann Marie Ferris
    Kenneth Hess
    Ahmad O. Kaseb
    Milind M. Javle
    Gauri R. Varadhachary
    Robert A. Wolff
    James L. Abbruzzese
    Investigational New Drugs, 2011, 29 : 694 - 699
  • [3] A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer
    El-Rayes, Bassel Fuad
    Philip, Philip A.
    Sarkar, Fazlul H.
    Shields, Anthony F.
    Ferris, Ann Marie
    Hess, Kenneth
    Kaseb, Ahmad O.
    Javle, Milind M.
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Abbruzzese, James L.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (04) : 694 - 699
  • [4] Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
    Brodowicz, T
    Wolfram, RM
    Köstler, WJ
    Tomek, S
    Vaclavik, I
    Steger, GG
    Teleky, B
    Függer, R
    Jakesz, R
    Zielinski, CC
    ANTI-CANCER DRUGS, 2000, 11 (08) : 623 - 628
  • [5] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Hong Suk Song
    Young Rok Do
    Heung Moon Chang
    Min Hee Ryu
    Kyung Hee Lee
    Yeul Hong Kim
    Dae Sik Hong
    Jae Yong Cho
    Kyoung Eun Lee
    Si Young Kim
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 763 - 768
  • [6] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Song, Hong Suk
    Do, Young Rok
    Chang, Heung Moon
    Ryu, Min Hee
    Lee, Kyung Hee
    Kim, Yeul Hong
    Hong, Dae Sik
    Cho, Jae Yong
    Lee, Kyoung Eun
    Kim, Si Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 763 - 768
  • [7] A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
    Jo, Jung Hyun
    Jung, Dawoon E.
    Lee, Hee Seung
    Park, Soo Been
    Chung, Moon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Cho, Sangsook
    Song, Si Young
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (09) : 1565 - 1577
  • [8] Gemcitabine in combination with capecitabine compared with gemcitabine combined with erlotinib in locally advanced or metastatic pancreatic cancer
    Khatri, P.
    Kumari, P.
    Beniwal, S.
    Samdariya, S.
    ANNALS OF ONCOLOGY, 2016, 27 : 92 - 92
  • [9] Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
    Melnik, Marianne K.
    Webb, Craig P.
    Richardson, Patrick J.
    Luttenton, Charles R.
    Campbell, Alan D.
    Monroe, Thomas J.
    O'Rourke, Timothy J.
    Yost, Kathleen J.
    Szczepanek, Connie M.
    Bassett, Michelle R.
    Truszkowski, Kimberly J.
    Stein, Phyllis
    Van Brocklin, Matthew W.
    Davis, Alan T.
    Bedolla, Gabriela
    Vande Woude, George F.
    Koo, Han-Mo
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (08) : 2423 - 2429
  • [10] Erlotinib, gemcitabine, paclitaxel and radiation for locally advanced pancreatic cancer: A phase I study.
    Iannitti, D
    Dipetrillo, T
    Cruff, D
    Sambandam, S
    Maia, C
    Hughes, M
    Oldenburg, N
    Thornton, K
    Kennedy, T
    Safran, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 336S - 336S
12345